Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37372 Collegium Pharmaceutical, Inc. (Exact name of registrant as specified in its charter) Virginia (State o ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations & Corporate Communications Joe Ciaffoni - President, CEO & Director Colleen Tupper - CFO Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler & Co. Brandon Folkes - Cantor Fitzgerald Serge Belanger - Needham & Company Lachlan Hanbury-Brown - William Blair Greg Fraser - Truist Securities Disclai ...

| --- | --- | --- | |-------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | Q4 and FYE 2021 Earnings Report | | | | February 24, 2022 \| Nasdaq: COLL | | | | --- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37372 Collegium Pharmaceutical, Inc. (Exact name of registrant as specified in its charter) Virginia (State or other jurisdiction of ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Julie Fallon - Senior Vice President, Investor Relations, MacDougall Advisors Joe Ciaffoni - President, CEO & Director Colleen Tupper - EVP & CFO Scott Dreyer - EVP & Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler & Co. David Steinberg - Jefferies Serge Belanger - Needham & Company Oren Livnat - H.C. Wainwright Greg Fraser - Truist Securities Op ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37372 Collegium Pharmaceutical, Inc. (Exact name of registrant as specified in its charter) Virginia (Sta ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Alex Dasalla - Head, IR Joseph Ciaffoni - President, CEO & Director Colleen Tupper - EVP & CFO Scott Dreyer - EVP & Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler & Co. David Steinberg - Jefferies John Boyle - William Blair & Company Rohit Bhasin - Needham & Company Gregory Fraser - Truist Securities Oren Livnat - H.C. Wainwright & Co. Operator Gr ...

August 5, 2021 Collegium Pharmaceutical, Inc. Q2 2021 Earnings Report Forward‐Looking Statements and use of Non‐GAAP Financial Measures | --- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37372 Collegium Pharmaceutical, Inc. (Exact name of registrant as specified in its charter) Virginia (State or ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - President & Chief Executive Officer Paul Brannelly - Executive Vice President & Chief Financial Officer Scott Dreyer - Executive Vice President & Chief Commercial Officer Conference Call Participants Tim Lugo - William Blair David Steinberg - Jefferies David Amsellem - Piper Sandler Gregg Gilbert - Truist Securities Serge Belanger ...